By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ultragenyx Pharmaceuticals 

77 Digital Drive
Suite 210
Novato  California  94949  U.S.A.
Phone: 415-884-0223 Fax: 415-884-0562



Company News
Ultragenyx Pharmaceuticals (RARE) Reports Second Quarter 2014 Financial Results And Corporate Update 8/11/2014 7:49:58 AM
Ultragenyx Pharmaceuticals (RARE) To Present At Upcoming Investor Conferences 8/6/2014 8:42:18 AM
Ultragenyx Pharmaceuticals (RARE) Announces License Of Intellectual Property For The Treatment Of Epilepsy And Other Seizure-Related Disorders With Triheptanoin 8/5/2014 8:41:11 AM
Ultragenyx Pharmaceuticals (RARE) Appoints Sunil Agarwal, M.D. As Chief Medical Officer And Senior Vice President 7/23/2014 1:01:02 PM
Ultragenyx Pharmaceuticals (RARE) Announces Closing Of Public Offering Of Common Stock And Exercise Of Underwriters' Option To Purchase Additional Shares 7/14/2014 12:26:45 PM
Ultragenyx Pharmaceuticals (RARE) Announces Pricing Of Public Offering Of Common Stock 7/9/2014 10:42:50 AM
Ultragenyx Pharmaceuticals (RARE) Announces Proposed Public Offering Of Common Stock 7/8/2014 6:20:23 AM
Ultragenyx Pharmaceuticals (RARE) Announces Initiation Of A Phase 2 Study Of KRN23 For Pediatric X-Linked Hypophosphatemia In The US And EU 7/1/2014 9:07:09 AM
Ultragenyx Pharmaceuticals Announces Results From Phase 1/2 Study Of KRN23 In X-Linked Hypophosphatemia In Adults 6/24/2014 8:38:16 AM
Ultragenyx Pharmaceuticals To Present At The JMP Securities Healthcare Conference 6/18/2014 9:19:11 AM